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We report the case of a male patient with a cutaneous
cyst caused by Brucella with a negative serological test,
which was successfully treated with doxycycline and
rifampin.
A 45 year-old male patient (a farmer) was admitted to our
department because of daily febrile spikes of 38 8C, night
sweating and arthralgia. The symptoms had started 10 days
previously. He had a negative past medical history with no
respiratory problems.
On clinical examination, his general condition was satis-
factory apart from a rectal temperature of 37.5 8C. A cyst
with dimensions of 18  12 cm had appeared in the right
lumbar area, which was mobile and not painful (Figure 1).
It had developed two months earlier and was increasing
steadily in size.
A complete blood count and blood chemical tests were
within normal limits. X-rays of the chest and thoracic ver-
tebrae did not elicit any pathology; this was also the case
with an abdominal ultrasound. The immunoprofile including
rheumatoid agglutinin, complement levels (C3, C4), Mantoux
test, serum antibody titer for brucellosis, and rose Bengal
test were all within normal limits. Antibodies to HIV, Epstein—Figure 1 A cyst of 18  12 cm dimension, which was mobile
and not painful, appeared in the right lumbar area.
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negative. Blood cultures were sterile.
After a week of hospitalization, a diagnosis was obtained
from the cytological examination of the cystic fluid. Thirty
milliliters of thick material was aspirated and sent to the
laboratory for routine culture. The fluid had lymphocytosis
with low glucose levels and a positive titer for brucellosis
1/640 by the microagglutination test. Fluid cultures yielded
growth of a non-motile, Gram-negative, catalase- and
oxidase-positive coccobacillus.
The patient was treated with doxycycline (100 mg twice
daily) and rifampin (600 mg daily) for six weeks with clinical
improvement and gradual disappearance of the cyst during a
1-year follow-up.
Brucellosis is a prevalent bacterial zoonosis.1 Skin com-
plications are infrequent and affect less than 6% of
patients.2,3 Other authors have found incidence varying from
2% to 11%.4 The various skin manifestations described in the
literature include non-pruritic purpuric lesions from leuko-
cytoclastic vasculitis, urticaria-like papules and plaques,
papulonodular eruption and tiny papules on the trunk and
proximal extremities, multiple mucocutaneous abscesses,
or erythema nodosum-like deep dermal nodules on the
legs.3,5—9 Brucella agglutinin test results have been persis-
tently negative.5,9
To our knowledge, there have been few reported cases of
soft tissue abscesses not originating from a leak with an
internal focus (such as thoracic spondylitis), caused by
Brucella with a negative serological test.4
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Hyponatraemia is an unusual complication of treatment with
highly active antiretroviral therapy (HAART) and to our
knowledge has not been reported in association with the
use of lopinavir—ritonavir in adults.1 Common to the protease
inhibitor class of antiretrovirals, the important well-recog-
nized side effects of lopinavir—ritonavir include hepatic
dysfunction, diabetes, and lipodystrophy syndrome with an
increased risk of pancreatitis.2
A 42-year old Zimbabwean man presented in July 2005
with confusion, headaches, blurring of vision, myalgia, dys-
phagia, and weight loss. He was noted to have oesophago-
pharyngeal candidiasis, bilateral uveitis, and was confused
with an expressive dysphasia. HIV serology was positive with
a CD4 count of 30 cells/mL and HIV viral load of
380 847 copies/mL. MRI of the head demonstrated symme-
trical white matter changes throughout the hemispheres in
keeping with an HIV dementia. CSF sampling showed 10
lymphocytes, 0 polymorphs, no organisms on Gram stain,
glucose 4.5 mmol/L (serum 8.9 mmol/L), and protein 0.69 g/
L. CSF PCR for herpes simplex virus, varicella-zoster virus,
enterovirus, mycobacteria, and JC virus was negative as was
cryptococcal antigen and mycobacterial culture. Toxoplasma
and syphilis serology was negative and cytomegalovirus viral
load in blood was<50 copies/mL. An EEGwas normal. He was
treated with fluconazole 200 mg once daily, co-trimoxazole
960 mg three times per week, and topical cyclopentolate
(1%), dexamethasone (0.1%), and timolol (0.25%) for uveitis.
Subsequently he was commenced on HAARTwith lamivudine
150 mg twice daily, tenofovir 245 mg once daily and lopina-
vir—ritonavir three tablets twice daily. Blood biochemistry
demonstrated a mild hepatitis with a transient rise in ALT to
184 IU/L prior to the introduction of HAART and probably
secondary to fluconazole. After five days of HAART he was
discharged with a declining ALT and plasma sodium of
133 mmol/L having been within the normal range (135—
145 mmol/L) on admission.
Two days later he was readmitted with worsening confu-
sion. He was clinically euvolemic and had a Glasgow coma
score (GCS) of 14/15. Investigations showed that cranial
imaging was unchanged but there was marked derangementin electrolytes with a serum sodium of 111 mmol/L, potas-
sium 4.8 mmol/L, urea 5.4 mmol/L, and creatinine 80 mmol/
L. Urine analysis was negative for protein, blood, nitrites,
and leukocytes. During the first five days of admission, the
paired urine and plasma osmolality ranged between 330 and
732 mOsm/kg and between 239 and 255 mOsm/kg, respec-
tively. The patient had a raised urine sodium of 76 mmol/L.
The low plasma osmolality, raised urine osmolality, and raised
urine sodium indicated a syndrome of inappropriate secre-
tion of antidiuretic hormone (SIADH). Repeat CSF sampling
was acellular, glucose 2.3 mmol/L (serum glucose 4.9 mmol/
L), and protein 0.34 mmol/L. He was treated for SIADH by
fluid restriction and HAARTwas discontinued since temporally
this was the most likely cause. Investigations to identify an
alternative etiology were negative including thyroid func-
tion, synacthen test (serum cortisol response to intramus-
cular tetracosactide) for adrenal insufficiency, chest X-ray,
and a septic screen. EEG demonstrated intermittent bursts of
a partial seizure pattern. Anticonvulsant therapy with sodium
valproate was commenced. Over six days the serum sodium
returned to normal. HAARTwas reintroduced with lamivudine
150 mg twice daily, tenofovir 245 mg once daily, and ataza-
navir—ritonavir. Electrolytes remained normal and subse-
quently tenofovir was substituted with abacavir, since the
latter has greater CNS penetration and may be beneficial in
the setting of HIV dementia.3,4
Use of lopinavir—ritonavir is set to rise as clinical trials
suggest superior clinical efficacy, no known de novo resis-
tance in treatment-naı¨ve individuals, and a reported side-
effect profile to date that is favorable.5,6 Since the only
change in the second HAART regimen was a switch from
lopinavir to atazanavir, this report indicates that lopinavir
was the most likely cause of the abrupt drop in sodium when
using lopinavir boosted with ritonavir. Normal urine analysis
did not suggest any direct tubular damage. Drugs used in the
management of HIV-related infections are known to precipi-
tate hyponatraemia through an SIADH effect (pyrazinamide,
ethambutol),7 an amiloride-like effect on the renal tubules
(high dose trimethoprim),8 or by as yet undefined mechan-
isms (amphotericin B, pentamidine).8 HAART-associated
hyponatremia is rare and described only with zalcitabine
(Roche1 product information) and lopinavir—ritonavir in
children.1 Laboratory investigations indicate that induction
